United States Human Vaccine Market Report & Forecast 2021-2027

Publisher Name :
Date: 16-Sep-2021
No. of pages: 113
Inquire Before Buying

United States Human Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses)

United States Human Vaccine Market Segment Percentages, By Type, 2020 (%)

- Varicella

- Influenza

- Polio

- Hepatitis A

- Rabies

- BCG

- Hepatitis B

- Pertussis, Diphtheria, Tetanus

- Pneumococcal

- Rota vaccine

United States Human Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses)

United States Human Vaccine Market Segment Percentages, By Application, 2020 (%)

- Adults

- Children

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Human Vaccine revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Human Vaccine revenues share in United States market, 2020 (%)

Key companies Human Vaccine sales in United States market, 2016-2021 (Estimated), (M Doses)

Key companies Human Vaccine sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- CNBG

- Changsheng Life

- Zhifei

- ChengDa Bio

- Kangtai

- SINOVAC BIOTECH

- Hissen

- Walvax Biotechnology

- GSK

- SANOFI

- Rong An

- NuoCheng Bio

- Hualan Bio

- Tiantan biological

- Changchun Baike

- Adimmune

- Zhongyianke Biotech

- Bharat Biotech

- Bavarian Nordic

- Sanofi-Pasteur

- Indian Immunologicals

- KANGH

- Henan Grand Biopharma

- ZhongKe Biopharm

- Zhuoyi Biological

United States Human Vaccine Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Human Vaccine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Human Vaccine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Human Vaccine Overall Market Size
2.1 United States Human Vaccine Market Size: 2021 VS 2027
2.2 United States Human Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Human Vaccine Sales: 2016-2027
3 Company Landscape
3.1 Top Human Vaccine Players in United States Market
3.2 Top United States Human Vaccine Companies Ranked by Revenue
3.3 United States Human Vaccine Revenue by Companies
3.4 United States Human Vaccine Sales by Companies
3.5 United States Human Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Human Vaccine Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Human Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Vaccine Players in United States Market
3.8.1 List of Tier 1 Human Vaccine Companies in United States
3.8.2 List of Tier 2 and Tier 3 Human Vaccine Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Human Vaccine Market Size Markets, 2021 & 2027
4.1.2 Varicella
4.1.3 Influenza
4.1.4 Polio
4.1.5 Hepatitis A
4.1.6 Rabies
4.1.7 BCG
4.1.8 Hepatitis B
4.1.9 Pertussis, Diphtheria, Tetanus
4.1.10 Pneumococcal
4.1.11 Rota vaccine
4.2 By Type - United States Human Vaccine Revenue & Forecasts
4.2.1 By Type - United States Human Vaccine Revenue, 2016-2021
4.2.2 By Type - United States Human Vaccine Revenue, 2022-2027
4.2.3 By Type - United States Human Vaccine Revenue Market Share, 2016-2027
4.3 By Type - United States Human Vaccine Sales & Forecasts
4.3.1 By Type - United States Human Vaccine Sales, 2016-2021
4.3.2 By Type - United States Human Vaccine Sales, 2022-2027
4.3.3 By Type - United States Human Vaccine Sales Market Share, 2016-2027
4.4 By Type - United States Human Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Human Vaccine Market Size, 2021 & 2027
5.1.2 Adults
5.1.3 Children
5.2 By Application - United States Human Vaccine Revenue & Forecasts
5.2.1 By Application - United States Human Vaccine Revenue, 2016-2021
5.2.2 By Application - United States Human Vaccine Revenue, 2022-2027
5.2.3 By Application - United States Human Vaccine Revenue Market Share, 2016-2027
5.3 By Application - United States Human Vaccine Sales & Forecasts
5.3.1 By Application - United States Human Vaccine Sales, 2016-2021
5.3.2 By Application - United States Human Vaccine Sales, 2022-2027
5.3.3 By Application - United States Human Vaccine Sales Market Share, 2016-2027
5.4 By Application - United States Human Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 CNBG
6.1.1 CNBG Corporation Information
6.1.2 CNBG Overview
6.1.3 CNBG Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.1.4 CNBG Human Vaccine Product Description
6.1.5 CNBG Recent Developments
6.2 Changsheng Life
6.2.1 Changsheng Life Corporation Information
6.2.2 Changsheng Life Overview
6.2.3 Changsheng Life Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.2.4 Changsheng Life Human Vaccine Product Description
6.2.5 Changsheng Life Recent Developments
6.3 Zhifei
6.3.1 Zhifei Corporation Information
6.3.2 Zhifei Overview
6.3.3 Zhifei Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.3.4 Zhifei Human Vaccine Product Description
6.3.5 Zhifei Recent Developments
6.4 ChengDa Bio
6.4.1 ChengDa Bio Corporation Information
6.4.2 ChengDa Bio Overview
6.4.3 ChengDa Bio Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.4.4 ChengDa Bio Human Vaccine Product Description
6.4.5 ChengDa Bio Recent Developments
6.5 Kangtai
6.5.1 Kangtai Corporation Information
6.5.2 Kangtai Overview
6.5.3 Kangtai Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.5.4 Kangtai Human Vaccine Product Description
6.5.5 Kangtai Recent Developments
6.6 SINOVAC BIOTECH
6.6.1 SINOVAC BIOTECH Corporation Information
6.6.2 SINOVAC BIOTECH Overview
6.6.3 SINOVAC BIOTECH Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.6.4 SINOVAC BIOTECH Human Vaccine Product Description
6.6.5 SINOVAC BIOTECH Recent Developments
6.7 Hissen
6.7.1 Hissen Corporation Information
6.7.2 Hissen Overview
6.7.3 Hissen Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.7.4 Hissen Human Vaccine Product Description
6.7.5 Hissen Recent Developments
6.8 Walvax Biotechnology
6.8.1 Walvax Biotechnology Corporation Information
6.8.2 Walvax Biotechnology Overview
6.8.3 Walvax Biotechnology Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.8.4 Walvax Biotechnology Human Vaccine Product Description
6.8.5 Walvax Biotechnology Recent Developments
6.9 GSK
6.9.1 GSK Corporation Information
6.9.2 GSK Overview
6.9.3 GSK Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.9.4 GSK Human Vaccine Product Description
6.9.5 GSK Recent Developments
6.10 SANOFI
6.10.1 SANOFI Corporation Information
6.10.2 SANOFI Overview
6.10.3 SANOFI Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.10.4 SANOFI Human Vaccine Product Description
6.10.5 SANOFI Recent Developments
6.11 Rong An
6.11.1 Rong An Corporation Information
6.11.2 Rong An Overview
6.11.3 Rong An Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.11.4 Rong An Human Vaccine Product Description
6.11.5 Rong An Recent Developments
6.12 NuoCheng Bio
6.12.1 NuoCheng Bio Corporation Information
6.12.2 NuoCheng Bio Overview
6.12.3 NuoCheng Bio Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.12.4 NuoCheng Bio Human Vaccine Product Description
6.12.5 NuoCheng Bio Recent Developments
6.13 Hualan Bio
6.13.1 Hualan Bio Corporation Information
6.13.2 Hualan Bio Overview
6.13.3 Hualan Bio Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.13.4 Hualan Bio Human Vaccine Product Description
6.13.5 Hualan Bio Recent Developments
6.14 Tiantan biological
6.14.1 Tiantan biological Corporation Information
6.14.2 Tiantan biological Overview
6.14.3 Tiantan biological Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.14.4 Tiantan biological Human Vaccine Product Description
6.14.5 Tiantan biological Recent Developments
6.15 Changchun Baike
6.15.1 Changchun Baike Corporation Information
6.15.2 Changchun Baike Overview
6.15.3 Changchun Baike Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.15.4 Changchun Baike Human Vaccine Product Description
6.15.5 Changchun Baike Recent Developments
6.16 Adimmune
6.16.1 Adimmune Corporation Information
6.16.2 Adimmune Overview
6.16.3 Adimmune Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.16.4 Adimmune Human Vaccine Product Description
6.16.5 Adimmune Recent Developments
6.17 Zhongyianke Biotech
6.17.1 Zhongyianke Biotech Corporation Information
6.17.2 Zhongyianke Biotech Overview
6.17.3 Zhongyianke Biotech Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.17.4 Zhongyianke Biotech Human Vaccine Product Description
6.17.5 Zhongyianke Biotech Recent Developments
6.18 Bharat Biotech
6.18.1 Bharat Biotech Corporation Information
6.18.2 Bharat Biotech Overview
6.18.3 Bharat Biotech Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.18.4 Bharat Biotech Human Vaccine Product Description
6.18.5 Bharat Biotech Recent Developments
6.19 Bavarian Nordic
6.19.1 Bavarian Nordic Corporation Information
6.19.2 Bavarian Nordic Overview
6.19.3 Bavarian Nordic Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.19.4 Bavarian Nordic Human Vaccine Product Description
6.19.5 Bavarian Nordic Recent Developments
6.20 Sanofi-Pasteur
6.20.1 Sanofi-Pasteur Corporation Information
6.20.2 Sanofi-Pasteur Overview
6.20.3 Sanofi-Pasteur Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.20.4 Sanofi-Pasteur Human Vaccine Product Description
6.20.5 Sanofi-Pasteur Recent Developments
6.21 Indian Immunologicals
6.21.1 Indian Immunologicals Corporation Information
6.21.2 Indian Immunologicals Overview
6.21.3 Indian Immunologicals Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.21.4 Indian Immunologicals Human Vaccine Product Description
6.21.5 Indian Immunologicals Recent Developments
6.22 KANGH
6.22.1 KANGH Corporation Information
6.22.2 KANGH Overview
6.22.3 KANGH Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.22.4 KANGH Human Vaccine Product Description
6.22.5 KANGH Recent Developments
6.23 Henan Grand Biopharma
6.23.1 Henan Grand Biopharma Corporation Information
6.23.2 Henan Grand Biopharma Overview
6.23.3 Henan Grand Biopharma Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.23.4 Henan Grand Biopharma Human Vaccine Product Description
6.23.5 Henan Grand Biopharma Recent Developments
6.24 ZhongKe Biopharm
6.24.1 ZhongKe Biopharm Corporation Information
6.24.2 ZhongKe Biopharm Overview
6.24.3 ZhongKe Biopharm Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.24.4 ZhongKe Biopharm Human Vaccine Product Description
6.24.5 ZhongKe Biopharm Recent Developments
6.25 Zhuoyi Biological
6.25.1 Zhuoyi Biological Corporation Information
6.25.2 Zhuoyi Biological Overview
6.25.3 Zhuoyi Biological Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.25.4 Zhuoyi Biological Human Vaccine Product Description
6.25.5 Zhuoyi Biological Recent Developments
7 United States Human Vaccine Production Capacity, Analysis
7.1 United States Human Vaccine Production Capacity, 2016-2027
7.2 Human Vaccine Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Human Vaccine Supply Chain Analysis
9.1 Human Vaccine Industry Value Chain
9.2 Human Vaccine Upstream Market
9.3 Human Vaccine Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Human Vaccine Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Human Vaccine in United States Market
Table 2. Top Human Vaccine Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Human Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Human Vaccine Revenue Share by Companies, 2016-2021
Table 5. United States Human Vaccine Sales by Companies, (M Doses), 2016-2021
Table 6. United States Human Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Human Vaccine Price (2016-2021) & (USD/Dose)
Table 8. Manufacturers Human Vaccine Product Type
Table 9. List of Tier 1 Human Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Human Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Varicella
Table 12. Major Manufacturers of Influenza
Table 13. By Type - United States Human Vaccine Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Human Vaccine Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Human Vaccine Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Human Vaccine Sales (M Doses), 2016-2021
Table 17. By Type - United States Human Vaccine Sales (M Doses), 2022-2027
Table 18. By Application - United States Human Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Human Vaccine Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Human Vaccine Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Human Vaccine Sales (M Doses), 2016-2021
Table 22. By Application - United States Human Vaccine Sales (M Doses), 2022-2027
Table 23. CNBG Corporation Information
Table 24. CNBG Description and Major Businesses
Table 25. CNBG Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 26. CNBG Human Vaccine Product
Table 27. CNBG Recent Developments
Table 28. Changsheng Life Corporation Information
Table 29. Changsheng Life Description and Major Businesses
Table 30. Changsheng Life Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 31. Changsheng Life Human Vaccine Product
Table 32. Changsheng Life Recent Developments
Table 33. Zhifei Corporation Information
Table 34. Zhifei Description and Major Businesses
Table 35. Zhifei Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 36. Zhifei Human Vaccine Product
Table 37. Zhifei Recent Developments
Table 38. ChengDa Bio Corporation Information
Table 39. ChengDa Bio Description and Major Businesses
Table 40. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 41. ChengDa Bio Human Vaccine Product
Table 42. ChengDa Bio Recent Developments
Table 43. Kangtai Corporation Information
Table 44. Kangtai Description and Major Businesses
Table 45. Kangtai Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 46. Kangtai Human Vaccine Product
Table 47. Kangtai Recent Developments
Table 48. SINOVAC BIOTECH Corporation Information
Table 49. SINOVAC BIOTECH Description and Major Businesses
Table 50. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 51. SINOVAC BIOTECH Human Vaccine Product
Table 52. SINOVAC BIOTECH Recent Developments
Table 53. Hissen Corporation Information
Table 54. Hissen Description and Major Businesses
Table 55. Hissen Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 56. Hissen Human Vaccine Product
Table 57. Hissen Recent Developments
Table 58. Walvax Biotechnology Corporation Information
Table 59. Walvax Biotechnology Description and Major Businesses
Table 60. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 61. Walvax Biotechnology Human Vaccine Product
Table 62. Walvax Biotechnology Recent Developments
Table 63. GSK Corporation Information
Table 64. GSK Description and Major Businesses
Table 65. GSK Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 66. GSK Human Vaccine Product
Table 67. GSK Recent Developments
Table 68. SANOFI Corporation Information
Table 69. SANOFI Description and Major Businesses
Table 70. SANOFI Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 71. SANOFI Human Vaccine Product
Table 72. SANOFI Recent Developments
Table 73. Rong An Corporation Information
Table 74. Rong An Description and Major Businesses
Table 75. Rong An Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 76. Rong An Human Vaccine Product
Table 77. Rong An Recent Developments
Table 78. NuoCheng Bio Corporation Information
Table 79. NuoCheng Bio Description and Major Businesses
Table 80. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 81. NuoCheng Bio Human Vaccine Product
Table 82. NuoCheng Bio Recent Developments
Table 83. Hualan Bio Corporation Information
Table 84. Hualan Bio Description and Major Businesses
Table 85. Hualan Bio Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 86. Hualan Bio Human Vaccine Product
Table 87. Hualan Bio Recent Developments
Table 88. Tiantan biological Corporation Information
Table 89. Tiantan biological Description and Major Businesses
Table 90. Tiantan biological Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 91. Tiantan biological Human Vaccine Product
Table 92. Tiantan biological Recent Developments
Table 93. Changchun Baike Corporation Information
Table 94. Changchun Baike Description and Major Businesses
Table 95. Changchun Baike Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 96. Changchun Baike Human Vaccine Product
Table 97. Changchun Baike Recent Developments
Table 98. Adimmune Corporation Information
Table 99. Adimmune Description and Major Businesses
Table 100. Adimmune Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 101. Adimmune Human Vaccine Product
Table 102. Adimmune Recent Developments
Table 103. Zhongyianke Biotech Corporation Information
Table 104. Zhongyianke Biotech Description and Major Businesses
Table 105. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 106. Zhongyianke Biotech Human Vaccine Product
Table 107. Zhongyianke Biotech Recent Developments
Table 108. Bharat Biotech Corporation Information
Table 109. Bharat Biotech Description and Major Businesses
Table 110. Bharat Biotech Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 111. Bharat Biotech Human Vaccine Product
Table 112. Bharat Biotech Recent Developments
Table 113. Bavarian Nordic Corporation Information
Table 114. Bavarian Nordic Description and Major Businesses
Table 115. Bavarian Nordic Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 116. Bavarian Nordic Human Vaccine Product
Table 117. Bavarian Nordic Recent Developments
Table 118. Sanofi-Pasteur Corporation Information
Table 119. Sanofi-Pasteur Description and Major Businesses
Table 120. Sanofi-Pasteur Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 121. Sanofi-Pasteur Human Vaccine Product
Table 122. Sanofi-Pasteur Recent Developments
Table 123. Indian Immunologicals Corporation Information
Table 124. Indian Immunologicals Description and Major Businesses
Table 125. Indian Immunologicals Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 126. Indian Immunologicals Human Vaccine Product
Table 127. Indian Immunologicals Recent Developments
Table 128. KANGH Corporation Information
Table 129. KANGH Description and Major Businesses
Table 130. KANGH Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 131. KANGH Human Vaccine Product
Table 132. KANGH Recent Developments
Table 133. Henan Grand Biopharma Corporation Information
Table 134. Henan Grand Biopharma Description and Major Businesses
Table 135. Henan Grand Biopharma Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 136. Henan Grand Biopharma Human Vaccine Product
Table 137. Henan Grand Biopharma Recent Developments
Table 138. ZhongKe Biopharm Corporation Information
Table 139. ZhongKe Biopharm Description and Major Businesses
Table 140. ZhongKe Biopharm Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 141. ZhongKe Biopharm Human Vaccine Product
Table 142. ZhongKe Biopharm Recent Developments
Table 143. Zhuoyi Biological Corporation Information
Table 144. Zhuoyi Biological Description and Major Businesses
Table 145. Zhuoyi Biological Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 146. Zhuoyi Biological Human Vaccine Product
Table 147. Zhuoyi Biological Recent Developments
Table 148. Human Vaccine Production Capacity (M Doses) of Key Manufacturers in United States Market, 2019-2021 (M Doses)
Table 149. United States Human Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 150. Human Vaccine Market Opportunities & Trends in United States Market
Table 151. Human Vaccine Market Drivers in United States Market
Table 152. Human Vaccine Market Restraints in United States Market
Table 153. Human Vaccine Raw Materials
Table 154. Human Vaccine Raw Materials Suppliers in United States Market
Table 155. Typical Human Vaccine Downstream
Table 156. Human Vaccine Downstream Clients in United States Market
Table 157. Human Vaccine Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Human Vaccine Product Picture
Figure 2. Human Vaccine Segment by Type
Figure 3. Human Vaccine Segment by Application
Figure 4. United States Human Vaccine Market Overview: 2020
Figure 5. United States Human Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Human Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. Human Vaccine Sales in United States Market: 2016-2027 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Human Vaccine Revenue in 2020
Figure 9. Varicella Product Picture
Figure 10. Influenza Product Picture
Figure 11. Polio Product Picture
Figure 12. Hepatitis A Product Picture
Figure 13. Rabies Product Picture
Figure 14. By Type - United States Human Vaccine Sales Market Share, 2016-2027
Figure 15. By Type - United States Human Vaccine Revenue Market Share, 2016-2027
Figure 16. By Type - United States Human Vaccine Price (USD/Dose), 2016-2027
Figure 17. Adults
Figure 18. Children
Figure 19. By Application - United States Human Vaccine Sales Market Share, 2016-2027
Figure 20. By Application - United States Human Vaccine Revenue Market Share, 2016-2027
Figure 21. By Application - United States Human Vaccine Price (USD/Dose), 2016-2027
Figure 22. CNBG Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Changsheng Life Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Zhifei Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. ChengDa Bio Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Kangtai Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. SINOVAC BIOTECH Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Hissen Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Walvax Biotechnology Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. GSK Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. SANOFI Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Rong An Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. NuoCheng Bio Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Hualan Bio Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Tiantan biological Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Changchun Baike Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. Adimmune Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Zhongyianke Biotech Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Bharat Biotech Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Bavarian Nordic Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Sanofi-Pasteur Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Indian Immunologicals Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. KANGH Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Henan Grand Biopharma Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. ZhongKe Biopharm Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Zhuoyi Biological Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. United States Human Vaccine Production Capacity (M Doses), 2016-2027
Figure 48. Human Vaccine Industry Value Chain
Figure 49. Marketing Channels
  • Global Peptic Ulcer Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 20-Oct-2021        Price: US 3480 Onwards        Pages: 98
    The Peptic Ulcer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest rese......
  • China Capecitabine Fumarate Market Report & Forecast 2021-2027
    Published: 19-Oct-2021        Price: US 3400 Onwards        Pages: 93
    China Capecitabine Fumarate Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Capecitabine Fumarate Market Segment Percentages, By Type, 2020 (%) - Capecitabine Fumarate Oral - Capecitabine Fumarate Infusion China Capecitabine Fumarate Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Capecitabine Fumarate Market Segment Percentages, By Application, 2020 (%) - Breast Cancer - Rectal Cancer - ......
  • China Caffeine Citrate Market Report & Forecast 2021-2027
    Published: 19-Oct-2021        Price: US 3400 Onwards        Pages: 93
    China Caffeine Citrate Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT) China Caffeine Citrate Market Segment Percentages, By Type, 2020 (%) - Injection - Oral Solution - Tablet China Caffeine Citrate Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT) China Caffeine Citrate Market Segment Percentages, By Application, 2020 (%) - Pharmaceuticals - Others Competitor Analysis The report a......
  • China Axitinib Market Report & Forecast 2021-2027
    Published: 19-Oct-2021        Price: US 3400 Onwards        Pages: 92
    China Axitinib Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Axitinib Market Segment Percentages, By Type, 2020 (%) - Injection - Others China Axitinib Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Axitinib Market Segment Percentages, By Application, 2020 (%) - Renal Cancer Treatment - Others Competitor Analysis The report also provides analysis of leading market partic......
  • Global Indocyanine Green (CAS 3599-32-4) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 19-Oct-2021        Price: US 3480 Onwards        Pages: 86
    The Indocyanine Green (CAS 3599-32-4) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to ......
  • China Atracurium Market Report & Forecast 2021-2027
    Published: 18-Oct-2021        Price: US 3400 Onwards        Pages: 92
    China Atracurium Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Atracurium Market Segment Percentages, By Type, 2020 (%) - 25mg - 50mg China Atracurium Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Atracurium Market Segment Percentages, By Application, 2020 (%) - Hospital - Clinic - ASCs - Others Competitor Analysis The report also provides analysis of lead......
  • China Analgesics Market Report & Forecast 2021-2027
    Published: 18-Oct-2021        Price: US 3400 Onwards        Pages: 91
    China Analgesics Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units) China Analgesics Market Segment Percentages, By Type, 2020 (%) - Non-Steroidal Anti-Inflammatory Drug - Central Pain Killers China Analgesics Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units) China Analgesics Market Segment Percentages, By Application, 2020 (%) - Hospital - Pharmacy - Family Competitor Analysis T......
  • Global and Japan Pneumonia Vaccine Market Insights, Forecast to 2027
    Published: 18-Oct-2021        Price: US 3900 Onwards        Pages: 144
    Pneumonia Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pneumonia Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the Pneumonia Vaccine mar......
  • Global and China Organ Transplant Immunosuppressant Drugs Market Insights, Forecast to 2027
    Published: 18-Oct-2021        Price: US 3900 Onwards        Pages: 139
    Organ Transplant Immunosuppressant Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Organ Transplant Immunosuppressant Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, th......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs